Will lower income countries get cheaper generic versions of Merck’s COVID-19 pill?
The plan to roll out Merck & Co’s promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once…